Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries

Recent Patents on Anti-Infective Drug Discovery

Volumn 7, Issue 2, 2012, Pages 111-122

  Desbois, Andrew P ^a  

^a UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Antibacterial; Antifungal; Decolonisation; Disinfectant; Growth promoter; Lauric acid; Mastitis; Wound therapy

Indexed keywords

10 UNDECENOIC ACID; BACTERIAL ENZYME; BACTERIAL TOXIN; CAPROLEIC ACID; CLOTRIMAZOLE; COSMETIC; FATTY ACID; HYPOCHLORITE SODIUM; IODINE; PSEUDOMONIC ACID; SILVER; UNCLASSIFIED DRUG;

ACNE; AGRICULTURE; ANIMAL FOOD; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTISEPSIS; BACTEREMIA; BACTERIAL VIRULENCE; BIOFILM; BURN; DENTAL CARIES; DERMATOMYCOSIS; DISINFECTION; FOOD PRESERVATION; FOOD PROCESSING; GASTROINTESTINAL INFECTION; GINGIVA DISEASE; GROWTH INHIBITION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LIPID COMPOSITION; LUNG INFECTION; MASTITIS; MEDICAL DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COLONIZATION; MICROBIAL CONTAMINATION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SKIN DECONTAMINATION; SKIN INFECTION; SKIN IRRITATION; STOMACH ULCER; SURGICAL INFECTION; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

AGRICULTURE; ANIMALS; ANTI-INFECTIVE AGENTS; FATTY ACIDS; HUMANS; INDUSTRY; MEDICINE;

EID: 84863971660     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489112801619728     Document Type: Review

References (145)

1. Thormar H. Antibacterial effects of lipids: historical review (1881 to 1960). In: Thormar H, Ed. Lipids and essential oils as antimicrobial agents. Philadelphia: John Wiley & Sons, Ltd 2011: 25-45.
2. Desbois AP, Smith VJ. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol 2010; 85: 1629-42.
3. Kanai K, Kondo E. Antibacterial and cytotoxic aspects of longchain fatty acids as cell surface events: Selected topics. Japan J Med Sci Biol 1979; 32: 135-74.
4. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 2001; 117: 44-51.
5. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Grampositive bacteria. Infect Immun 2005; 73: 4512-21.
6. Takigawa H, Nakagawa H, Kuzukawa M, Mori H, Imokawa G. Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonisation by Staphylococcus aureus. Dermatology 2005; 211: 240-8.
7. Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids 2007; 150: 1-11.
8. Drake DR, Brogden KA, Dawson DV, Wertz PW. Antimicrobial lipids at the skin surface. J Lipid Res 2008; 49: 4-11.
9. Lee JT, Jansen M, Yilma AN, Nguyen A, Desharnais R, Porter E. Antimicrobial lipids: Novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis. Am J Rhino Allergy 2010; 24: 99-104.
10. Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang C-M. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating defensin-2 expression. J Invest Dermatol 2010; 130: 985-94.
11. Chen C-H, Wang Y, Nakatsuji T, Liu Y-T, Zouboulis CC, Gallo RL, et al. An innate bactericidal oleic acid affective against skin infection of methicillin-resistant Staphylococcus aureus: A therapy concordant with evolutionary medicine. J Microbiol Biotechnol 2011; 21: 391-9.
12. Zasloff M. Observations on the remarkable (and mysterious) wound-healing process of the bottlenose dolphin. J Invest Dermatol 2011; 131: 2503-5.
13. Weber H. Fatty acid-derived signals in plants. Trend Plant Sci 2002; 7: 217-24.
14. Küpper FC, Gaquerel E, Bonenerg E-M, Morath S, Salaün J-P, Potin P. Early events in the perception of lipopolysaccharides in the brown alga Laminaria digitata include an oxidative burst and activation of fatty acid oxidation cascades. J Exp Bot 2006; 57: 1991-9.
15. Payne DJ. Antimicrobials-where next? Microbiol Today 2004; 31: 55-7
16. Hamad B. The antibiotics market. Nat Rev Drug Discov 2010; 9: 675-6.
17. Kakisawa H, Asari F, Kusumi T, Toma T, Sakurai T, Oohusa T, et al. An allelopathic fatty acid from the brown alga Cladosiphon okamuranus. Phytochemistry 1988; 27: 731-5.
18. Ikawa M, Sasner JJ, Haney JF. Inhibition of Chlorella growth by degradation and related products of linoleic and linolenic acids and the possible significance of polyunsaturated fatty acids in phytoplankton ecology. Hydrobiologia 1997; 356: 143-8.
19. Ungerfeld EM, Rust SR, Burnett RJ, Yokoyama MT, Wang JK. Effects of two lipids on in vitro ruminal methane production. Animal Feed Sci Technol 2005; 119: 179-85
20. Wu J-T, Chiang Y-R, Huang W-Y, Jane W-N. Cytotoxic effects of free fatty acids on phytoplankton algae and cyanobacteria. Aquat Toxicol 2006; 80: 338-45.
21. Alamsjah MA, Hirao S, Ishibashi F, Oda T, Fujita Y. Algicidal activity of polyunsaturated fatty acids derived from Ulva fasciata and Ulva pertusa (Ulvaceae, Chlorophyta) on phytoplankton. J Appl Phycol 2008; 20: 713-20.
22. Carballeira NM. New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents. Prog Lipid Res 2008; 47: 50-61.
23. Thibane VS, Kock JLF, Ells R, van Wyk PWJ, Pohl CH. Effect of marine polyunsaturated fatty acids on biofilm formation of Candida albicans and Candida dubliniensis. Mar Drugs 2010; 8: 2597-604.
24. Pohl CH, Kock JLF, Thibane VS. Antifungal free fatty acids: a review. In: Méndez-Vilas A, Ed. Science against microbial pathogens: Communicating current research and technological advances, Badajoz: Formatex 2011; 1: 61-71.
25. Kumaratilake LM, Robinson BS, Ferrante A, Poulos A. Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: In vitro effects on Plasmodium falciparum and in vivo effects on P. berghei. J Clin Invest 1992; 89: 961-7.
26. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrob Agents Chemother 1972; 2: 23-8.
27. McLain N, Ascanio R, Baker C, Strohaver RA, Dolan JW. Undecylenic acid inhibits morphogenesis of Candida albicans. Antimicrob Agents Chemother 2000; 44: 2873-5.
28. Mil-Homens D, Bernardes N, Fialho AM. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia. FEMS Microbiol Lett 2012; 328: 61-9.
29. Nakatsuji T, Kao MC, Fang J-Y, Zouboulis CC, Zhang L, Gallo RL et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009; 129: 2480-8.
30. Desbois AP, Mearns-Spragg A, Smith VJ. A fatty acid from the diatom Phaeodactylum tricornutum is antibacterial against diverse bacteria including multi-resistant Staphylococcus aureus (MRSA). Mar Biotechnol 2009; 11: 45-52.
31. Tsuchido T, Hiraoka T, Takano M, Shibasaki I. Involvement of autolysin in cellular lysis of Bacillus subtilis induced by short and medium-chain fatty acids. J Bacteriol 1985; 162: 42-6.
32. Chamberlain NR, Mehrtens BG, Xiong Z, Kapral FA, Boardman JL, Rearick JI. Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in Staphylococcus aureus 18Z. Infect Immun 1991; 59: 4332-7.
33. Wang L-L, Johnson EA. Inhibition of Listeria monocytogenes by fatty acids and monoglycerides. Appl Environ Microbiol 1992; 58: 624-9.
34. Avis TJ, Bélanger RR. Specificity and mode of action of the antifungal fatty acid cis-9-heptadecenoic acid produced by Pseudozyma flocculosa. Appl Environ Microbiol 2001; 67: 956-60.
35. Sun CQ, O'Connor CJ, Roberton AM. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 2003; 36: 9-17.
36. Kitahara T, Koyama N, Matsuda J, Aoyama Y, Hirakata Y, Kamihira S, et al. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 2004; 27: 1321-6.
37. Skivanová E, Marounek M. Influence of pH on antimicrobial activity of organic acids against rabbit enteropathogenic strain of Escherichia coli. Folia Microbiol 2007; 52: 70-2.
38. Yang J, Hou X, Mir PS, McAllister TA. Anti-Escherichia coli O157:H7 activity of free fatty acids under varying pH. Can J Microbiol 2010; 56: 263-7.
39. Yang D, Pornpattananangkul D, Nakatsuji T, Chan M, Carson D, Huang C-M, et al. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes. Biomaterials 2009; 30: 6035-40.
40. Lacey RW, Lord VL. Sensitivity of staphylococci to fatty acids: novel inactivation of linolenic acid by serum. J Med Microbiol 1981; 14: 41-9.
41. Bergsson G, Steingrímsson Ó, Thormar H. In vitro susceptibilities of Neisseria gonorrhoeae to fatty acids and monoglycerides. Antimicrob Agents Chemother 1999; 43: 2790-2.
42. Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H. Killing of Gram-positive cocci by fatty acids and monoglycerides. APMIS 2001a; 109:670-8.
43. Shin SY, Bajpai VK, Kim HR, Kang SC. Antibacterial activity of eicosapentaenoic acid (EPA) against foodborne and food spoilage microorganisms. LWT 2007a; 40: 1515-9.
44. Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother 2001b; 45: 3209-12.
45. Kenny JG, Ward D, Josefsson E, Jonsson I-M, Hinds J, Rees HH, et al. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 2009; 4: e4344.
46. Boyaval P, Corre C, Dupuis C, Roussel E. Effects of free fatty acids on propionic acid bacteria. Lait 1995; 75: 17-29.
47. Wojtczak L, Wickowski MR. The mechanisms of fatty acid induced proton permeability of the inner mitochondrial membrane. J Bioenerg Biomembr 1999; 31: 447-55.
48. Schönfeld P, Wojtczak L. Fatty acids as modulators of the cellular production of reactive oxygen species. Free Radic Biol Med 2008; 45: 231-41.
49. Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett 2005; 579: 5157-62.
50. Sado-Kamdem SL, Vannini L, Guerzoni ME. Effect of linolenic, capric and lauric acid on the fatty acid biosynthesis in Staphylococcus aureus. Int J Food Microbiol 2009; 129: 288-94.
51. Petschow BW, Batema RP, Ford LL. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 1996; 40: 302-6.
52. 18 fatty acids. Folia Microbiol 2003; 48: 731-5.
53. Clarke SR, Mohamed R, Bian L, Routh AF, Kokai-Kun JF, Mond JJ et al. The Staphylococcus aureus surface protein isdA mediates resistance to innate defenses of human skin. Cell Host Microb 2007; 1: 1-14.
54. Kohler T, Weidenmaier C, Peschel A. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J Bacteriol 2009; 191: 4482-4.
55. Mortensen JE, Shryock TR, Kapral FA. Modification of bactericidal fatty acids by an enzyme of Staphylococcus aureus. J Med Microbiol 1992; 36: 293-8.
56. Gardner AJ, Percival SL, Cochrane CA. Biofilms and role to infection and disease in veterinary medicine. In: Percival SL, Knottenbelt DC, Cochrane CA, Eds. Biofilms and Veterinary Medicine. Heidelberg: Springer-Verlag 2011: 111-28.
57. Kurihara H, Goto Y, Aida M, Hosokawa M, Takahashi K. Antibacterial activity against cariogenic bacteria and the inhibition of insoluble glucan production by free fatty acids obtained from dried Gloiopeltis furcata. Fish Sci 1999; 65: 129-32.
58. Kankaanpää PE, Salminen SJ, Isolauri E, Lee YK. The influence of polyunsaturated fatty acids on probiotic growth and adhesion. FEMS Microbiol Lett 2001; 194: 149-53.
59. Stenz L, François P, Fischer A, Huyghe A, Tangomo M, Hernandez D, et al. Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in Staphylococcus aureus. FEMS Microbiol Lett 2008; 287: 149-55.
60. Davies DG, Marques CNH. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J Bacteriol 2009; 191: 1393-403.
61. Liaw S-J, Lai H-C, Wang W-B. Modulation of swarming and virulence by fatty acids through the rsbA protein in Proteus mirabilis. Infect Immun 2004; 72: 6836-45
62. Ruzin A, Novick RP. Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J Bacteriol 2000; 182: 2668-71.
63. Osawa K, Miyazaki K, Shimura S, Okuda J, Matsumoto M, Ooshima T. Identification of cariostatic substances in the cacao bean husk: their anti-glucosyltransferase and antibacterial activities. J Dent Res 2001; 80: 2000-4.
64. Clément M, Tremblay J, Lange M, Thibodeau J, Belhumeur P. Whey-derived free fatty acids suppress the germination of Candida albicans in vitro. FEMS Yeast Res 2007; 7: 276-85.
65. Fernandez-Lopez R, Machón C, Longshaw CM, Martin S, Molin S, Zechner EL et al. Unsaturated fatty acids are inhibitors of bacterial conjugation. Microbiology 2005; 151: 3517-26.
66. Whittle E, Basketter DA. The in vitro skin corrosivity test: Development of method using human skin. Toxicol in vitro 1993; 7: 265-8.
67. Kabara JJ. Toxicological, bacteriocidal and fungicidal properties of fatty acids and some derivatives. J Am Oil Chem Soc 1979; 56: 760A-7A.
68. Dee, A., Gradle, C. Fatty acid antimicrobial. US7553871 (2009).
69. Huang C-M, Chen C-H, Pornpattananangkul D, Zhang L, Chan M, Hsieh M-F, et al. Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 2011; 32: 214-21.
70. Wille JJ, Kydonieus A. Palmitoleic acid isomer (C16:1-6) in human skin sebum is effective against Gram-positive bacteria. Skin Pharmacol Appl Skin Physiol 16: 176-87.
71. Reinikainen M, Meriluoto JAO, Spoof L, Harada K-I. The toxicities of a polyunsaturated fatty acid and a microcystin to Daphnia magna. Environ Toxicol 2001; 16: 444-8.
72. Kitahara T, Aoyama Y, Hirakata Y, Kamihira S, Kohno S, Ichikawa N, et al. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillinresistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2006; 27: 51-7.
73. Lee D-Y, Huang C-M, Nakatsuji T, Thiboutot D, Kang S-A, Monestier M, et al. Histone H4 is a major component of the antimicrobial action of human sebocytes. J Invest Dermatol 2009; 129: 2489-96.
74. Martinez JG, Waldon M, Huang Q, Alvarez S, Oren A, Sandoval N, et al. Membrane-targeted synergistic activity of docosahexaenoic acid and lysozyme against Pseudomonas aeruginosa. Biocem J 2009; 419: 193-200.
75. Hinton A, Jr., Ingram KD. Influence of ethylenediamine-N-N'-disuccinic acid (EDDS) concentration on the bactericidal activity of fatty acids in vitro. J Food Saf 2012; 32: 102-7.
76. Cottarel G, Wierzbowski J. Combination drugs, an emerging option for antibacterial therapy. Trends Biotechnol 2007; 25: 547-55.
77. Folan, M.A., O'Brien, C., Dunne, C. Free fatty acid blends and use thereof. US20100317734 (2010).
78. Cardoso CRB, Souza MA, Ferro EAV, Favoreto S, Pena JDO. Influence of topical administration of n-3 and n-6 essential and n-9 nonessential fatty acids on the healing of cutaneous wounds. Wound Rep Reg 2004; 12: 235-43.
79. Yaqoob P. Fatty acids and the immune system: from basic science to clinical applications. Proc Nutr Soc 2004; 63: 89-104.
80. Pereira LM, Hatanaka E, Martins EF, Oliveira F, Liberti EA, Farsky SH, et al. Effect of oleic acid and linoleic acid on the inflammatory phase of wound healing in rats. Cell Biochem Funct 2008; 26: 197-204.
81. Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47: 147-55.
82. Shingel KI, Faure M-P, Azoulay L, Roberge C, Deckelbaum RJ. Solid emulsion gel as a vehicle for delivery of polyunsaturated fatty acids: implications for tissue repair, dermal angiogenesis and wound healing. J Tissue Eng Regen Med 2008; 2: 383-93.
83. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent antiinflammatory and insulin-sensitizing effects. Cell 2010; 142: 687-98.
84. Rodrigues HG, Vinolo MAR, Magdalon J, Fujiwara H, Cavalcanti DMH, Farsky SHP, et al. Dietary free oleic and linolenic acid enhances neutrophil function and modulates the inflammatory response in rats. Lipids 2010; 45: 809-19.
85. Kristmundsdóttir T, Skúlason S. Lipids as active ingredients in pharmaceuticals, cosmetics and health foods. In: Thormar H, Ed. Lipids and essential oils as antimicrobial agents. Philadelphia: John Wiley & Sons, Ltd. 2011: 151-77.
86. Hesslink, R., Jr., Spencer, W. P. Compositions comprising myristic acid and uses thereof. US20120029078 (2012).
87. Coates T, Hu Y, Bax R, Page C. The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 2002; 1: 895-910.
88. Lange, M., Clement, M., Tremblay, J., Thibodeau, J., Belhumeur, P., Shareck, J. Antimicrobial agents derived from cream. US20080075786 (2008).
89. Hart R, Bell-Syer SEM, Crawford F, Torgerson DJ, Young P, Russell I. Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ 1999; 319: 79-82.
90. Bergsson G, Arnfinnsson J, Karlsson SM, Steingrímsson Ó, Thormar H. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother 1998; 42: 2290-4.
91. Won S-R, Hong M-J, Kim Y-M, Li CY, Kim J-W, Rhee H-I. Oleic acid: an efficient inhibitor of glucosyltransferase. FEBS Lett 2007; 581: 4999-5002.
92. Huang CB, George B, Ebersole JL. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol 2010; 55: 555-60.
93. Sprong RC, Hulstein MFE, Van der Meer R. Bactericidal activities of milk lipids. Antimicrob Agents Chemother 2001; 45: 1298-1301.
94. Vogt, S., Kuhn, K.-D., Buchner, H. Surgical suture material with an antimicrobial surface and process for providing an antimicrobial coating on surgical suture material. US20080103526 (2008).
95. Roby, M. Antimicrobial suture coating. US6878757 (2005).
96. nd May 2012).
97. Sikes, C., Steckel, M., Ranade, S.V. Medical devices for the release of therapeutic agents. EP2402043 (2012)
98. McConeghy KW, Mikolich DJ, LaPlante KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009; 29: 263-80.
99. Corne P, Marchandin H, Jonquet O, Campos J, Bañuls A-L. Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respiratory tract infections of critically ill patients. J Clin Microbiol 2005; 43: 3491-3.
100. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: Systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005; 26: 916-22.
101. Bode LGM, Klutymans JAJW, Wertheim HFL, Bogaers D, Vandenbrouke-Grauls CMJE, Roosendaal R, et al. Preventing surgicalsite infections in nasal carriers of Staphylococcus aureus. New Engl J Med 2010; 362: 9-17
102. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus? A focus on evidence from intensive care. J Antimicrob Chemother 2011; 66: ii41-7.
103. Simor AE, Stuart TL, Louie L, Watt C, Ofner-Agostini M, Gravel D, et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother 2007; 51: 3880-6.
104. LaPlante KL, Caffrey AR, Gupta K. Prevention of surgical-site infections. New Engl J Med 2010; 362: 1540-1.
105. Coates T, Bax R, Coates A. Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. J Antimicrob Chemother 2009; 64: 9-15.
106. Desbois AP, Lang S, Gemmell CG, Coote PJ. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillinresistant Staphylococcus aureus (MRSA). J Appl Microbiol 2010; 108: 723-30.
107. Hogan JS, Pankey JW, Duthie AH. Growth inhibition of mastitis pathogens by long-chain fatty acids. J Dairy Sci 1987; 70: 927-34.
108. Nair MKM, Joy J, Vasudevan P, Hinckley L, Hoagland TA, Venkitanarayanan KS. Antibacterial effect of caprylic acid and monocaprylin on major bacterial mastitis pathogens. J Dairy Sci 2005; 88: 3488-95.
109. James GA, Swogger E, Wolcott R, deLancey Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Rep Reg 2008; 16: 37-44.
110. th April 2012).
111. Fletcher J. Best practice-choosing an appropriate antibacterial dressing. Nurs Times 2006; 102: 46-9.
112. Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: Management strategies. J Wound Care 2008; 17: 502-8.
113. Ammons MCB. Anti-biofilm strategies and the need for innovations in wound care. Recent Pat Antiinfect Drug Discov 2010; 5: 10-17.
114. Pieper B, Caliri MHL. Nontraditional wound care: A review of the evidence for the use of sugar, papaya/papain, and fatty acids. J Wound Ostomy Cont 2004; 30: 175-83.
115. European Union (2005) On additives for use in animal nutrition. Commission Regulation (EC) No 378/2005 of 4 March 2005.
116. Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poultry Sci 2005; 84: 634-43.
117. Walters D, Raynor L, Mitchell A, Walker R, Walker K. Antifungal activities of four fatty acids against plant pathogenic fungi. Mycopathologia 2004; 157: 87-90.
118. Liu S, Ruan W, Li J, Xu H, Wang J, Gao Y, et al. Biological control of phytopathogenic fungi by fatty acids. Mycopathologia 2008; 166: 93-102.
119. Feldlaufer MF, Knox DA, Lusby WR, Shimanuki H. Antimicrobial activity of fatty acids against Bacillus larvae, the causative agent of American foulbrood disease. Apidologie 1993; 24: 95-9.
120. Torgerson, K.L., Buck, R.L., Hedlund, N., Mendell, S., Stevenson, R.D., Gradle, C.D., Dee, A.O., Hanson, J.S., Gingrich, G. Hoof bath system. US7661393 (2010).
121. th April 2012)
122. Richter, F.L., Rinehardt, D.J. Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof. US7109241 (2006).
123. Wei, G.J., McSherry, D.D., Richter, F.L., Staub, R.K. Antimicrobial composition useful for the treatment of bovine mastitis. US6582734 (2003).
124. Molly, K., Bruggemann, G. Medium chain fatty acids applicable as antimicrobial agents. US20030176500 (2003).
125. Decuypere, J., Dierick, N. The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements. EP1059041 (2000).
126. Dierick NA, Decuypere JA, Molly K, Van Beek E, Vanderbeke E. The combined use of triacylglycerides (TAGs) containing medium chain fatty acids (MCFAs) and exogenous lipolytic enzymes as an alternative to nutritional antibiotics in piglet nutrition. II. In vivo release of MCFAs in gastric cannulated and slaughtered piglets by endogenous and exogenous lipases; effects on the luminal gut flora and growth performance. Livest Prod Sci 2002; 76: 1-16.
127. Skivanová E, Molatová Z, Marounek M. Effects of caprylic acid and triacylglycerols of both caprylic and capric acid in rabbits experimentally infected with enteropathogenic Escherichia coli O103. Vet Microbiol 2008; 126: 372-6.
128. Dohme F, Machmüller A, Wasserfallen A, Kreuzer M. Ruminal methanogenesis as influenced by individual fatty acids supplemented to complete ruminant diets. Lett Appl Microbiol 2001; 32: 47-51.
129. Shelby, N.J., Godfrey, M.T. Feed supplement for animals for reducing methane production. US20090285931 (2009).
130. Defoirdt T, Sorgeloos P, Bossier P. Alternatives to antibiotics for the control of bacterial disease in aquaculture. Curr Opin Microbiol 2011; 14: 251-8.
131. Benkendorff K, Davis AR, Rogers CN, Bremner JB. Free fatty acids and sterols in the benthic spawn of aquatic molluscs, and their associated antimicrobial properties. J Exp Mar Biol Ecol 2005; 316: 29-44.
132. Kabara, J.J. Antimicrobial preservative compositions and methods. US6638978 (2003).
133. Thormar H, Hilmarsson H. Antimicrobial lipids as disinfectants, antiseptics and sanitizers. In: Thormar H, Ed. Lipids and essential oils as antimicrobial agents. Philadelphia: John Wiley & Sons, Ltd 2011: 179-201.
134. Zullo, J.L., Anderson, J.C., Carney, J.F., de Souza, M.L., Sperber, W.H., Tupy, M.J., Wagener, E.H. Antimicrobial compositions, methods and systems. US20080033026 (2008).
135. Ravigadevi, S., Tan, Y.A. An antimicrobial composition based on botanical extracts from oil palm vegetation liquor. WO2009072862 (2009).
136. Dembitsky VM, Srebnik M. Natural halogenated fatty acids: their analogues and derivatives. Prog Lipid Res 2002; 41: 315-67.
137. Shin SY, Bajpai VK, Kim HR, Kang SC. Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria. Int J Food Microbiol 2007b; 113: 233-6.
138. Galbraith H, Miller TB. Effect of metal cations and pH on the antibacterial activity and uptake of long chain fatty acids. J Appl Bacteriol 1973; 36: 635-46.
139. Ko HL, Heczko PB, Pulverer G. Differential susceptibility of Propionibacterium acnes. P. granulosum and P. avidum to free fatty acids. J Invest Dermatol 1978; 71: 363-5.
140. Saito H, Tomioka H, Yoneyama T. Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids. Antimicrob Agents Chemother 1984; 26: 164-9.
141. Xiong Z, Kapral FA. Carotenoid pigment levels in Staphylococcus aureus and sensitivity to oleic acid. J Med Microbiol 1992; 37: 192-4.
142. Nakai SA, Siebert KJ. Organic acid inhibition models for Listeria innocua, Listeria ivanovii, Pseudomonas aeruginosa and Oeococcus oeni. Food Microbiol 2004; 21: 67-72.
143. Kelsey JA, Bayles KW, Shafii B, McGuire MA. Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 2006; 41: 951-61.
144. Zhang H, Zhang L, Peng L, Dong X, Wu D, Wu VC, et al. Quantitative structure-activity relationships of antimicrobial fatty acids and derivatives against Staphylococcus aureus. J Zhejiang Univ Sci B 2012; 13: 83-93.
145. Clinical Laboratory Standards Institute. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard M11-A4. 4th ed. CLSI: Wayne 1997.